Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  eltrombopag olamine
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Eltrombopag Olamine in Treating Thrombocytopenia in Patients with Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Status: Active
Phase: Phase III, Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2011-0319, NCI-2011-03336, NCT01428635
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Relapsed Multiple Myeloma Undergoing Chemotherapy
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 11-373, NCI-2012-00821, NCT01484314
Lenalidomide and Eltrombopag Olamine in Treating Patients with Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2012-407, NCI-2013-01219, 115479, 12-007, RV--MDS-PI-0645, NCT01772420
Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Status: Active
Phase: Phase II
Type: Supportive care
Age: 60 and over
Trial IDs: CASE4913, NCI-2014-00252, GSK IIS, 14-147, NCT02071901
Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 2012-0920, NCI-2013-02348, NCT01927731
Eltrombopag Olamine and Filgrastim in Mobilizing Stem Cells in Patients with Multiple Myeloma Undergoing Peripheral Blood Stem Cell Transplant
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 to 70
Trial IDs: 10-346, NCI-2011-00899, NCT01286675
Start Over